Reported Earnings • Jul 28
Second quarter 2026 earnings released: EPS: Rp9.29 (vs Rp7.48 in 2Q 2025) Second quarter 2026 results: EPS: Rp9.29. Revenue: Rp709.4b (up 8.9% from 2Q 2025). Net income: Rp26.7b (down 33% from 2Q 2025). Profit margin: 3.8% (down from 6.1% in 2Q 2025). The decrease in margin was driven by higher expenses. Announcement • May 23
PT Suparma Tbk, Annual General Meeting, Jun 30, 2026 PT Suparma Tbk, Annual General Meeting, Jun 30, 2026. Reported Earnings • May 01
First quarter 2026 earnings released: EPS: Rp2.50 (vs Rp3.21 in 1Q 2025) First quarter 2026 results: EPS: Rp2.50 (down from Rp3.21 in 1Q 2025). Revenue: Rp653.0b (up 2.5% from 1Q 2025). Net income: Rp10.2b (down 22% from 1Q 2025). Profit margin: 1.6% (down from 2.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 01
Full year 2025 earnings released: EPS: Rp26.00 (vs Rp25.57 in FY 2024) Full year 2025 results: EPS: Rp26.00 (up from Rp25.57 in FY 2024). Revenue: Rp2.74t (flat on FY 2024). Net income: Rp106.2b (up 1.3% from FY 2024). Profit margin: 3.9% (up from 3.8% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. New Risk • Oct 26
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 5.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Profit margins are more than 30% lower than last year (2.1% net profit margin). Significant insider selling over the past 3 months (Rp3.6b sold). Market cap is less than US$100m (Rp1.20t market cap, or US$71.9m). Board Change • Oct 24
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Independent Commissioner Maria Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • May 05
PT Suparma Tbk, Annual General Meeting, Jun 10, 2025 PT Suparma Tbk, Annual General Meeting, Jun 10, 2025. Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: Rp20.18 (vs Rp7.72 in 3Q 2023) Third quarter 2024 results: EPS: Rp20.18 (up from Rp7.72 in 3Q 2023). Revenue: Rp686.1b (up 5.5% from 3Q 2023). Net income: Rp65.9b (up 171% from 3Q 2023). Profit margin: 9.6% (up from 3.7% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • Jul 31
Second quarter 2024 earnings released: EPS: Rp8.89 (vs Rp12.20 in 2Q 2023) Second quarter 2024 results: EPS: Rp8.89 (down from Rp12.20 in 2Q 2023). Revenue: Rp618.2b (up 2.5% from 2Q 2023). Net income: Rp26.4b (down 31% from 2Q 2023). Profit margin: 4.3% (down from 6.4% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. New Risk • Jul 08
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.6% net profit margin). Market cap is less than US$100m (Rp908.4b market cap, or US$55.4m). Announcement • May 09
PT Suparma Tbk, Annual General Meeting, Jun 14, 2024 PT Suparma Tbk, Annual General Meeting, Jun 14, 2024. Location: Vasa Hotel Surabaya Jawa Timur Indonesia Reported Earnings • May 04
First quarter 2024 earnings released: EPS: Rp7.00 (vs Rp25.65 in 1Q 2023) First quarter 2024 results: EPS: Rp7.00 (down from Rp25.65 in 1Q 2023). Revenue: Rp657.6b (down 5.9% from 1Q 2023). Net income: Rp22.6b (down 72% from 1Q 2023). Profit margin: 3.4% (down from 12% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 7% per year. New Risk • Apr 03
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.7% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.7% net profit margin). Market cap is less than US$100m (Rp1.09t market cap, or US$68.4m). Reported Earnings • Apr 03
Full year 2023 earnings released: EPS: Rp57.00 (vs Rp107 in FY 2022) Full year 2023 results: EPS: Rp57.00 (down from Rp107 in FY 2022). Revenue: Rp2.66t (down 15% from FY 2022). Net income: Rp178.7b (down 47% from FY 2022). Profit margin: 6.7% (down from 11% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year. Valuation Update With 7 Day Price Move • Oct 31
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to Rp338, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 4x in the Forestry industry in Indonesia. Total returns to shareholders of 85% over the past three years. Reported Earnings • Jul 30
Second quarter 2023 earnings released: EPS: Rp12.30 (vs Rp10.32 in 2Q 2022) Second quarter 2023 results: EPS: Rp12.30 (up from Rp10.32 in 2Q 2022). Revenue: Rp603.0b (down 23% from 2Q 2022). Net income: Rp38.5b (up 4.8% from 2Q 2022). Profit margin: 6.4% (up from 4.7% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 19
PT Suparma Tbk, Annual General Meeting, Jun 08, 2023 PT Suparma Tbk, Annual General Meeting, Jun 08, 2023, at 03:00 Coordinated Universal Time. Location: Meeting Room of PT Suparma Tbk Jl. Mastrip No. 856 Surabaya Indonesia Agenda: To consider the approval on the company's annual report including the company's audited financial statements and the board of commissioners' Supervisory Duty Report for financial year ended on December 31, 2022; to consider to determine the use of the company's net profit for the financial year ended on December 31, 2022; to consider to appoint the Registered Public Accountant and/or Registered Public Accounting Firm that will Audit the company's financial statements for the financial year ended on December 31, 2023; and to transact such other business issues. Board Change • Nov 16
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. 4 highly experienced directors. 1 independent director (3 non-independent directors). Corporate Secretary & Independent Director Hendro Luhur is the most experienced director on the board, commencing their role in 1998. Independent Commissioner M. Lanniwati was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Reported Earnings • Nov 06
Third quarter 2022 earnings released: EPS: Rp54.76 (vs Rp72.09 in 3Q 2021) Third quarter 2022 results: EPS: Rp54.76. Revenue: Rp814.9b (up 15% from 3Q 2021). Net income: Rp130.9b (up 12% from 3Q 2021). Profit margin: 16% (in line with 3Q 2021). Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment improved over the past week After last week's 27% share price gain to Rp555, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 15x in the Forestry industry in Indonesia. Total returns to shareholders of 145% over the past three years. Valuation Update With 7 Day Price Move • May 30
Investor sentiment improved over the past week After last week's 16% share price gain to Rp755, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 19x in the Forestry industry in Indonesia. Total returns to shareholders of 266% over the past three years. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Commissioner Tan Juanto was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 16% share price gain to Rp815, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 325% over the past three years. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improved over the past week After last week's 16% share price gain to Rp685, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 247% over the past three years. Valuation Update With 7 Day Price Move • Nov 24
Investor sentiment improved over the past week After last week's 19% share price gain to Rp585, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 213% over the past three years. Reported Earnings • Nov 07
Third quarter 2021 earnings released: EPS Rp79.47 (vs Rp7.85 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp710.0b (up 30% from 3Q 2020). Net income: Rp117.1b (up 435% from 3Q 2020). Profit margin: 17% (up from 4.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Nov 02
Investor sentiment improved over the past week After last week's 15% share price gain to Rp422, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 10x in the Forestry industry in Indonesia. Total returns to shareholders of 131% over the past three years. Reported Earnings • Jul 30
Second quarter 2021 earnings released: EPS Rp24.89 (vs Rp30.91 in 2Q 2020) The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: Rp616.9b (up 43% from 2Q 2020). Net income: Rp37.7b (down 56% from 2Q 2020). Profit margin: 6.1% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 27% per year. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment improved over the past week After last week's 19% share price gain to Rp390, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 112% over the past three years. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improved over the past week After last week's 17% share price gain to Rp610, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 11x in the Forestry industry in Indonesia. Total returns to shareholders of 123% over the past three years. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment improved over the past week After last week's 24% share price gain to Rp520, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 12x in the Forestry industry in Indonesia. Total returns to shareholders of 82% over the past three years. Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment improved over the past week After last week's 17% share price gain to Rp370, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 14x in the Forestry industry in Indonesia. Total returns to shareholders of 24% over the past three years. Is New 90 Day High Low • Feb 26
New 90-day high: Rp336 The company is up 3.0% from its price of Rp326 on 27 November 2020. The Indonesian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 62% over the same period. Is New 90 Day High Low • Jan 28
New 90-day low: Rp276 The company is down 1.0% from its price of Rp280 on 27 October 2020. The Indonesian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 61% over the same period. Is New 90 Day High Low • Nov 11
New 90-day high: Rp296 The company is up 15% from its price of Rp258 on 13 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 1.0% over the same period. Reported Earnings • Oct 29
Third quarter earnings released Over the last 12 months the company has reported total profits of Rp118.1b, down 19% from the prior year. Total revenue was Rp2.18t over the last 12 months, down 15% from the prior year. 
